28
Participants
Start Date
March 12, 2018
Primary Completion Date
June 30, 2019
Study Completion Date
October 5, 2020
Avelumab
"Autologous Dendritic Cells vaccine: A dose of ADC at days 1, 14, 28, 42 and 56 (total of 5 doses), and thereafter every 6 months until disease progression (maximum of 6 additional doses) or unacceptable toxicity.~Avelumab will be administered intravenously at a dose of 10 mg per kilogram of body weight, every 14 days until disease progression or unacceptable toxicity."
Hospital Universitario y Politécnico La Fe, Valencia
Hospital Universitario Miguel Servet, Zaragoza
Hospital Clínic Barcelona, Barcelona
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Universitario La Paz, Madrid
Hospital Universitario Puerta de Hierro, Madrid
Instituto Valenciano de Oncología, Valencia
Hospital Clínico Universitario Lozano Blesa, Zaragoza
Grupo Espanol Multidisciplinario del Cancer Digestivo
OTHER